Telemedicine in diabetes care is rapidly transforming how patients manage chronic conditions like Type 1 and Type 2 diabetes. From continuous glucose monitoring (CGM) to app-based coaching and virtual...Read More
The U.S. diabetes market is undergoing a rapid transformation, fueled by technological innovation, rising obesity rates, and growing demand for smarter, more personalized treatment options. Valued at ...Read More
For decades, injectable insulin and GLP-1 receptor agonists have been the gold standard in diabetes management. But for millions of patients, daily injections are painful, inconvenient, and often lead...Read More
The Ultimate US Diabetes Market Overview explores the current state of the US diabetes market in the year 2025, breaking down key industry trends, major players, and technological innovations that are...Read More
Diabetes treatment is evolving rapidly, with pharmaceutical companies racing to develop more effective therapies. The combined cost of diagnosed diabetes and prediabetes in the United States amounts t...Read More
The continuous glucose monitoring (CGM) market has experienced strong but slowing growth in the U.S. blood glucose monitoring sector. Valued at over $6 billion in 2024, the market is only projected to...Read More
Earlier last week, the US Food and Drug Administration (FDA) approved Novo Nordisk to utilize their already successful semaglutide drug, Ozempic, to reduce the risk of kidney failure and kidney diseas...Read More
Within the glucose monitoring market, continuous glucose monitoring (CGM) is a way for patients to continually measure their glucose levels in different settings. Four companies compete to gain a domi...Read More
Researchers at UCSF have developed a method to help detect diabetes using a smartphone. They have developed a deep-learning technology that can be combined with a mobile app to offer a low-cost method...Read More
The most recent integrated continuous glucose monitor (iCGM) from Abbott, the Freestyle Libre 2, has been granted FDA approval for sale in the U.S. to adults and children over the age of four with dia...Read More